Actemra 160mg, a medication known scientifically as tocilizumab, is a a potent therapeutical agent primarily employed for the control of rheumatoid arthritis. This powerful agent functions by blocking the activity of interleukin-6 (IL-6), a regulatory protein vital in the inflammatory process. Moreover, Actemra exhibits efficacy in the management